Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.

NACompletedINTERVENTIONAL
Enrollment

734

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

July 31, 2011

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
BEHAVIORAL

pharmaceutical care intervention

Pharmaceutical care intervention, focused at improving inhalation technique and drug adherence in patients with Chronic Obstructive Pulmonary Disease (COPD).

Trial Locations (2)

Unknown

Ghent University, Ghent

Centre Hospitalier Universitaire du Sart Tilman, Liège

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University Ghent

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

University Hospital, Ghent

OTHER

NCT01260389 - Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study. | Biotech Hunter | Biotech Hunter